News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Juan P. Alderuccio: BTK inhibitors and degraders in Lymphoma and Chronic Lymphocytic Leukemia
Juan P. Alderuccio/X
Nov 4, 2024, 13:37

Juan P. Alderuccio: BTK inhibitors and degraders in Lymphoma and Chronic Lymphocytic Leukemia

Juan P. Alderuccio, Lymphoma Physician at Sylvester Comprehensive Cancer Center, shared on X about recent paper by him as co-author, titled “Navigating the changing landscape of BTK-targeted therapies for B cell lymphomas and chronic lymphocytic leukaemia” published on Nature Reviews Clinical Oncology.

Authors: Michele D. Stanchina, Skye Montoya, Alexey V. Danilov, Jorge J. Castillo, Alvaro J. Alencar, Julio C. Chavez, Chan Y. Cheah, Carlos Chiattone, Yucai Wang, Meghan Thompson, Paolo Ghia, Justin Taylor, Juan Pablo Alderuccio

Juan P. Alderuccio: BTK inhibitors and degraders in Lymphoma and Chronic Lymphocytic Leukemia

“Happy to share our paper on BTK inhibitors and degraders in lymsm and CLL with the participation of outstanding colleagues.”

Alexey V. Danilov Alvaro J. Alencar cancer Carlos Chiattone Chan Y. Cheah Jorge J. Castillo Juan P. Alderuccio Julio C. Chavez Justin Taylor Meghan Thompson Michele D. Stanchina Nature Reviews OncoDaily Oncology Paolo Ghia Skye Montoya Yucai Wang
Special Coverage
Blog
May 30, 2025, 06:50
Cecilia Pompili: Grateful to Join the ESTS25 Thoracic Surgery in LMICs Session
Blog
May 30, 2025, 06:43
Aakash Desai: Will you be at ASCO25?
Blog
May 30, 2025, 06:35
Jay Bradner: Molecular Determinants of Sotorasib Clinical Efficacy in KRASG12C-NSCLC
Blog
May 30, 2025, 06:25
Leonidas Platanias Announces “Exceptional” NCI Rating for Lurie Cancer Center
Blog
May 30, 2025, 06:09
Roberto Borea: Liquid Biopsy in the spotlight at ASCO25
Blog
May 30, 2025, 06:00
Hem-Onc Fellows Network Highlights ASCO 2025 Session on Visibility and Achievement for Trainees
Blog
May 30, 2025, 05:52
C. Jillian Tsai: Phase II Study of Pembrolizumab and Chemoradiation in Head and Neck Cancer
Blog
May 30, 2025, 05:42
Colorectal Cancer Alliance and PeerView Live at ASCO 2025 on Systemic Therapy Regimens in CRC
Blog
May 30, 2025, 05:33
IPOS - Fear of Cancer Recurrence Special Interest Group (FORwards) presents Meet the Expert
Blog
May 30, 2025, 01:27
$225,000 AACR Gertrude B. Elion Award Supports Junior Faculty Cancer Research - AACR
Blog
May 30, 2025, 01:15
Lung cancer is now the leading cause of cancer death among women worldwide - UICC
Blog
May 30, 2025, 01:04
Monica Kraft: New Evidence Supports As-Needed Albuterol and Budesonide for Mild Asthma